Literature DB >> 21187444

Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.

Angelika Stoecklinger1, Tekalign D Eticha, Mehrnaz Mesdaghi, Adrien Kissenpfennig, Bernard Malissen, Josef Thalhamer, Peter Hammerl.   

Abstract

The C-type lectin langerin/CD207 was originally discovered as a specific marker for epidermal Langerhans cells (LC). Recently, additional and distinct subsets of langerin(+) dendritic cells (DC) have been identified in lymph nodes and peripheral tissues of mice. Although the role of LC for immune activation or modulation is now being discussed controversially, other langerin(+) DC appear crucial for protective immunity in a growing set of infection and vaccination models. In knock-in mice that express the human diphtheria toxin receptor under control of the langerin promoter, injection of diphtheria toxin ablates LC for several weeks whereas other langerin(+) DC subsets are replenished within just a few days. Thus, by careful timing of diphtheria toxin injections selective states of deficiency in either LC only or all langerin(+) cells can be established. Taking advantage of this system, we found that, unlike selective LC deficiency, ablation of all langerin(+) DC abrogated the activation of IFN-γ-producing and cytolytic CD8(+) T cells after gene gun vaccination. Moreover, we identified migratory langerin(+) dermal DC as the subset that directly activated CD8(+) T cells in lymph nodes. Langerin(+) DC were also critical for IgG1 but not IgG2a Ab induction, suggesting differential polarization of CD4(+) T helper cells by langerin(+) or langerin-negative DC, respectively. In contrast, protein vaccines administered with various adjuvants induced IgG1 independently of langerin(+) DC. Taken together, these findings reflect a highly specialized division of labor between different DC subsets both with respect to Ag encounter as well as downstream processes of immune activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187444     DOI: 10.4049/jimmunol.1002557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance.

Authors:  Helen Strandt; Douglas Florindo Pinheiro; Daniel H Kaplan; Dagmar Wirth; Iris Karina Gratz; Peter Hammerl; Josef Thalhamer; Angelika Stoecklinger
Journal:  J Immunol       Date:  2017-07-24       Impact factor: 5.422

Review 2.  Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.

Authors:  Sharifa Al-Zahrani; Marija Zaric; Cian McCrudden; Chris Scott; Adrien Kissenpfennig; Ryan F Donnelly
Journal:  Expert Opin Drug Deliv       Date:  2012-04-05       Impact factor: 6.648

3.  Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.

Authors:  Marija Zaric; Oksana Lyubomska; Candice Poux; Mary L Hanna; Maeliosa T McCrudden; Bernard Malissen; Rebecca J Ingram; Ultan F Power; Christopher J Scott; Ryan F Donnelly; Adrien Kissenpfennig
Journal:  J Invest Dermatol       Date:  2014-09-22       Impact factor: 8.551

4.  Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; John W McBride; Cian M McCrudden; Eva M Vincente-Perez; Ryan F Donnelly; Helen O McCarthy
Journal:  Hum Vaccin Immunother       Date:  2016-11-15       Impact factor: 3.452

Review 5.  Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.

Authors:  Soledad Mac Keon; María Sol Ruiz; Silvina Gazzaniga; Rosa Wainstok
Journal:  Front Immunol       Date:  2015-05-20       Impact factor: 7.561

Review 6.  Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection.

Authors:  Masachika Senba; Naoki Mori
Journal:  Oncol Rev       Date:  2012-10-05

7.  Immune Reactions against Gene Gun Vaccines Are Differentially Modulated by Distinct Dendritic Cell Subsets in the Skin.

Authors:  Corinna Stefanie Weber; Katrina Hainz; Tekalign Deressa; Helen Strandt; Douglas Florindo Pinheiro; Roberta Mittermair; Jennifer Pizarro Pesado; Josef Thalhamer; Peter Hammerl; Angelika Stoecklinger
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

8.  HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunity.

Authors:  Tam Nguyen-Hoai; Dennis Kobelt; Oliver Hohn; Minh D Vu; Peter M Schlag; Bernd Dörken; Steven Norley; Martin Lipp; Wolfgang Walther; Antonio Pezzutto; Jörg Westermann
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

9.  A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.

Authors:  Laura Pattacini; Gregory J Mize; Jessica B Graham; Tayler R Fluharty; Tisha M Graham; Karen Lingnau; Benjamin Wizel; Beatriz Perdiguero; Mariano Esteban; Giuseppe Pantaleo; Mingchao Shen; Gregory A Spies; M Juliana McElrath; Jennifer M Lund
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization.

Authors:  Teerawan Rattanapak; James C Birchall; Katherine Young; Atsuko Kubo; Sayumi Fujimori; Masaru Ishii; Sarah Hook
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.